Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MOREAll products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
As cellular immunotherapy continues to revolutionize cancer treatment, the demand for precision, efficiency, and scalability in research is paramount. Creative Biolabs provides an elite portfolio of integrated CAR-T development kits, meticulously engineered to streamline your workflow, from genetic construction and viral packaging to functional validation and quality control.
Our CAR development kits are modularly designed and may include the following key components:
| Genetic Engineering & Vector Construction | ||
|---|---|---|
|
|
|
|
CAR Construction Kits For the design and assembly of CAR gene sequences (scFv, hinge, and signaling domains). |
CAR Virus Packaging Kits General systems for producing viral vectors. |
CAR Lentivirus Packaging Kits Specialized high-titer systems specifically for lentiviral vector production. |
| Cell Engineering & Expansion | ||
|
|
|
|
CAR Transfection Kits Optimized reagents for introducing genetic material into T-cells (via viral or non-viral methods). |
CAR-T Proliferation Test Kits Comprehensive assays designed to evaluate the expansion capacity, growth kinetics, and metabolic fitness of genetically engineered T cells following CAR modification. |
|
| Quality Control & Functional Validation | ||
|
|
|
|
CAR Expression Test Kits For quantifying the density and percentage of CAR expression on the cell surface. |
CAR-T Cytokine Release Test Kits To evaluate the functional activation and safety profile. |
CAR Quality Control Kits Comprehensive assays for safety testing, including purity, sterility, and vector copy number. |
Streamline your research from initial concept to final validation with our specialized kits designed for every critical milestone.
How to improve CAR construct transfection efficiency?
Optimize plasmid quality (high purity, endotoxin-free), DNA-to-reagent ratio, and cell density; use immune cell-specific reagents and validated protocols.
Common causes of low CAR lentivirus titer?
Suboptimal plasmid ratios, poor packaging cell health/over-confluency, inefficient transfection. Improve with high-viability cells, optimized plasmid stoichiometry, and standardized packaging kits.
Factors influencing CAR-T in vitro expansion?
Activation strength, cytokines, nutrients, culture environment. Use CAR-T Proliferation Test Kits to monitor growth/metabolism and optimize conditions.
If you are planning or optimizing a CAR-T research project and need guidance on kit selection or experimental design, our scientific support team is ready to assist you. Contact us to discuss your research goals and discover tailored solutions for your study.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
